MedChunk
Medically reviewed

Stem Cell Treatment for Ankylosing Spondylitis

Learn whether stem cell treatment works for ankylosing spondylitis, what research suggests, possible risks, FDA approval status, and proven treatment options.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateNov 19, 2026 11 min read

Stem cell treatment for ankylosing spondylitis is an experimental approach that has not been proven to be safe or effective for treating the disease. Researchers are interested in whether certain stem cells could help control inflammation, but there is not enough reliable clinical evidence to recommend this treatment routinely. Established medicines, exercise, and physical therapy remain the main ways to manage ankylosing spondylitis.

How Could Stem Cells Help Ankylosing Spondylitis?

Ankylosing spondylitis (AS) is a long-term inflammatory disease that mainly affects the spine and the joints connecting the spine to the pelvis. It belongs to a group of conditions called axial spondyloarthritis. Inflammation can cause back pain, stiffness, and reduced movement. Over time, some people develop changes in the spine, including areas where bones join together.

According to the National Health Service (NHS), ankylosing spondylitis has no known cure, and existing structural damage cannot be reversed. Available treatment focuses on relieving symptoms and helping slow disease progression.

Stem cells are special cells that can develop into certain other cell types. Some also have properties that researchers believe could influence inflammation and immune activity.

This has created interest in using stem cells for inflammatory diseases such as ankylosing spondylitis. However, a treatment that appears promising in laboratory research does not necessarily produce meaningful benefits in patients.

What Type of Stem Cells Are Being Investigated?

One area of interest involves mesenchymal stromal cells, often called mesenchymal stem cells or MSCs. These cells can be obtained from tissues such as bone marrow, fat, or umbilical cord tissue.

Researchers are studying their potential effects on the immune system and inflammatory processes. The aim is to determine whether these cells could eventually become useful in treating diseases involving abnormal inflammation.

For ankylosing spondylitis, important questions remain unanswered, including whether MSC treatment produces consistent clinical benefits, which cell preparations might be suitable, and whether the benefits would outweigh potential harms.

Does Stem Cell Therapy Actually Work for Ankylosing Spondylitis?

There is currently insufficient high-quality clinical evidence to establish stem cell therapy as an effective treatment for ankylosing spondylitis.

Although stem cell research is developing, findings from early investigations cannot establish that a treatment works for everyone or provides lasting disease control. Larger, carefully controlled studies are needed to determine whether any observed improvement is caused by the treatment and whether it lasts.

Clinical researchers need to answer several practical questions:

  • Can stem cell treatment reliably reduce spinal pain and inflammation?
  • Does it improve movement, physical function, or quality of life?
  • How long would any measurable benefit last?
  • Can it prevent structural damage or spinal fusion?
  • What short-term and long-term complications might occur?
  • How would its safety and effectiveness compare with established treatments?

At present, claims that stem cells can cure ankylosing spondylitis, permanently stop inflammation, or rebuild an already fused spine are not supported by established clinical evidence.

Is Stem Cell Treatment Approved for Ankylosing Spondylitis?

Stem cell therapy is not an established, approved treatment for ankylosing spondylitis in the United States.

The U.S. Food and Drug Administration (FDA) warns that many regenerative medicine products are marketed for conditions they have not been shown to treat safely or effectively. Its consumer guidance explains that FDA-approved stem cell products are limited to specific blood-forming cell products used for certain disorders of the blood-forming system, not inflammatory spinal conditions.

Approval requirements can differ between countries. However, a clinic offering a procedure does not establish that it has received regulatory approval or that the procedure is supported by reliable clinical evidence.

Patients should be particularly cautious when advertisements describe stem cell therapy as a permanent cure, promise guaranteed results, or suggest that established medications are no longer necessary.

What Are the Risks of Stem Cell Treatment?

The risks of stem cell treatment depend on the type of cells used, how they are collected and processed, and how the product is administered. Procedures offered by different clinics may not use the same methods or meet the same quality standards.

According to the FDA's patient information on regenerative medicine therapies, unapproved regenerative medicine products have been associated with serious safety problems.

Potential risks include:

  • Infection: Contamination during cell collection, processing, or administration can cause infections, including serious bloodstream infections.
  • Unwanted immune reactions: Some products may trigger harmful inflammatory or immune responses.
  • Injection or collection complications: Problems may occur at sites where cells are collected or administered.
  • Abnormal tissue growth: Certain unapproved cell products raise concerns about unwanted cell growth or tumor formation.
  • Unpredictable results: The procedure may produce no meaningful improvement despite its costs and potential risks.
  • Delayed effective care: Relying on an unproven treatment may delay medicines and rehabilitation that are supported by clinical evidence.

These are potential concerns associated with regenerative medicine products generally. They should not be interpreted as established complication rates for a specific stem cell procedure in ankylosing spondylitis. Reliable long-term safety information for this proposed use remains limited.

Can Stem Cells Reverse Spinal Fusion?

There is no established clinical evidence that stem cell treatment can reverse spinal fusion caused by ankylosing spondylitis.

Spinal fusion occurs when new bone forms between parts of the spine, reducing movement. This structural change differs from inflammation alone.

Even if an experimental treatment were eventually shown to reduce inflammation, that would not automatically mean it could restore movement to joints that have already fused.

Patients should distinguish between three different treatment goals: reducing pain, controlling active inflammation, and reversing permanent structural damage. Evidence supporting one goal does not establish that the others can be achieved.

What Treatments Are Proven to Help Ankylosing Spondylitis?

While stem cell therapy remains experimental, several established approaches can help manage ankylosing spondylitis. Treatment is generally coordinated by a rheumatologist, a doctor who specializes in inflammatory joint and autoimmune diseases.

The NHS treatment guidance for ankylosing spondylitis describes a combination of exercise, physiotherapy, and medication, with treatment adjusted according to symptoms and disease activity.

Anti-Inflammatory Medicines

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to relieve pain and stiffness. Examples include naproxen and ibuprofen.

These medicines may not be suitable for everyone. A clinician considers medical history, other medicines, potential side effects, and the amount of symptom relief when choosing a treatment.

Biologic and Targeted Medicines

If inflammation remains active despite initial treatment, a rheumatologist may recommend medicines that target specific inflammatory pathways.

Options include tumor necrosis factor (TNF) inhibitors, interleukin-17 (IL-17) inhibitors, and certain Janus kinase (JAK) inhibitors.

These medicines are different from stem cell therapy. They have been evaluated for inflammatory disease management and may be prescribed for appropriate patients under medical supervision.

The selection depends on disease activity, previous treatment response, other health conditions, and medicine-specific safety considerations.

Physical Therapy and Regular Exercise

Movement and rehabilitation are important parts of ankylosing spondylitis care. An appropriate exercise program can help maintain flexibility, posture, mobility, and physical function.

The American Physical Therapy Association summarizes clinical recommendations that strongly support physical therapy for people with active or stable ankylosing spondylitis. The recommendations favor active approaches, including supervised exercise, over relying only on passive treatments.

A physiotherapist can help develop a program based on spinal movement, pain, physical ability, and individual needs.

When Might Stem Cell Treatment Become an Option?

Stem cell therapy could become a possible treatment only if well-designed clinical studies demonstrate meaningful benefits and acceptable safety for people with ankylosing spondylitis.

Research would also need to identify appropriate cell products, administration methods, patient groups, and monitoring requirements.

Even if future research is encouraging, clinical use would depend on independent evaluation and the regulatory requirements of the country where the treatment is offered.

There is no established timeline for when, or whether, stem cell therapy will become a routine treatment for ankylosing spondylitis.

What Should You Ask Before Considering a Stem Cell Clinic?

People exploring experimental treatment should speak with their rheumatologist before agreeing to a procedure, particularly if they are already taking medicines that control inflammation.

Useful questions to discuss with the treating team include:

  • Is the treatment part of a formally registered and appropriately authorized clinical trial?
  • What evidence specifically supports its use for ankylosing spondylitis?
  • What type of cells will be used, and how are they processed and tested?
  • What complications have been reported with the proposed procedure?
  • How will treatment outcomes and possible adverse effects be monitored?
  • What medical care and financial arrangements are available if complications occur?
  • What established treatment options remain available?

A clinical trial registration number alone does not prove that a product is approved or effective. Patients should verify the study's oversight, eligibility requirements, and informed consent process with the research team.

Prescribed ankylosing spondylitis medicines should not be stopped or replaced with an experimental therapy without discussing the change with the treating clinician.

Making an Informed Treatment Decision

Stem cell treatment for ankylosing spondylitis remains an area of scientific investigation rather than an established treatment choice. Its proposed effects on inflammation are interesting, but reliable evidence of long-term benefit, safety, and protection against spinal damage is still insufficient.

For people living with ankylosing spondylitis, the most useful approach is to work with a rheumatologist to assess current disease activity, review treatment response, and consider proven medications alongside an individualized exercise program.

If symptoms remain disruptive or current treatment is not helping enough, a specialist can reassess the treatment plan and discuss appropriate alternatives, including whether participation in legitimate clinical research is an option.

Frequently Asked Questions

Common questions about the effectiveness, safety, and availability of stem cell treatment for ankylosing spondylitis.

Can stem cell therapy permanently cure ankylosing spondylitis?

No permanent cure using stem cell therapy has been established. Ankylosing spondylitis is a chronic inflammatory disease, and there is not enough reliable clinical evidence to show that stem cells can permanently stop the disease or prevent its return.

How long does stem cell treatment take to work for ankylosing spondylitis?

There is no scientifically established timeline for improvement because stem cell therapy is not a proven treatment for ankylosing spondylitis. Claims that symptoms will improve within a fixed number of days or weeks should be approached cautiously.

Can stem cell injections repair damaged spinal joints?

There is no established evidence that stem cell injections can repair spinal joints damaged by ankylosing spondylitis or reverse existing spinal fusion. Claims of complete spinal regeneration are not supported by reliable clinical evidence.

Is stem cell treatment safer than biologic medicines?

There is not enough evidence to conclude that stem cell treatment is safer than established biologic medicines for ankylosing spondylitis. Biologic treatments have known benefits and risks that clinicians can monitor, while the safety of experimental stem cell procedures remains uncertain.

Can I receive stem cell treatment if my current ankylosing spondylitis medicines are not working?

An inadequate response to current medicines does not automatically make experimental stem cell therapy an appropriate option. A rheumatologist can review disease activity, consider switching or adjusting established treatments, and discuss legitimate clinical trial opportunities when available.

Citations

  1. National Health Service (NHS) – Ankylosing Spondylitis Overview
  2. U.S. Food and Drug Administration – Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes
  3. U.S. Food and Drug Administration – Important Patient and Consumer Information About Regenerative Medicine Therapies
  4. National Health Service (NHS) – Ankylosing Spondylitis Treatment
  5. American Physical Therapy Association – Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Share this article